Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts

NCT02454738 ·Status: COMPLETED ·Phase: NA

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

NCT06674291 ·Status: NOT_YET_RECRUITING

Latent Tuberculosis Infection in Korean Health Care Workers

NCT03010111 ·Status: UNKNOWN ·Phase: NA

The Epidemiology of TST Change in Korea

NCT01850043 ·Status: COMPLETED

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

NCT03830671 ·Status: COMPLETED ·Phase: PHASE4

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

NCT02573350 ·Status: COMPLETED ·Phase: PHASE2

Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial

NCT06727864 ·Status: RECRUITING ·Phase: PHASE3

Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

NCT03822156 ·Status: COMPLETED

A Prospective Registry For Patients With Non-Tuberculous Mycobacterial (NTM) Pulmonary Disease in Korea.

NCT03934034 ·Status: NOT_YET_RECRUITING

Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment

NCT04655794 ·Status: UNKNOWN

Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers

NCT02602509 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis

NCT03678688 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis

NCT07003581 ·Status: COMPLETED

Improving the Management of Drug Resistant Tuberculosis in the UK

NCT02875574 ·Status: COMPLETED

Determining Risk in Latent Tuberculosis

NCT01571739 ·Status: TERMINATED

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

NCT01859923 ·Status: COMPLETED ·Phase: PHASE2

Improving the Diagnostic of Tuberculosis

NCT02861768 ·Status: COMPLETED ·Phase: NA

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers

NCT02387242 ·Status: SUSPENDED ·Phase: PHASE1

Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults

NCT01755598 ·Status: COMPLETED ·Phase: PHASE2

The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis

NCT00982969 ·Status: COMPLETED

Substudy of Protocol TB-018 (NCT01755598): Collection and Storage of Biological Samples for Evaluation of Correlates of TB (C-041-972)

NCT02097095 ·Status: COMPLETED

Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

NCT05473520 ·Status: RECRUITING ·Phase: PHASE3

Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis Drugs

NCT06539455 ·Status: ACTIVE_NOT_RECRUITING

The Incidence and Risk Factors of Side Effects During the Initial Phase of Rifater Therapy - a Prospective Study

NCT01182259 ·Status: UNKNOWN

New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis

NCT05621343 ·Status: RECRUITING